Coronavirus

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

ImmunoRank offers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins

Rapid, multiplex molecular tests will give labs flexibility and scalability as they plan for the upcoming flu season

The benefits of ending a trial early must be weighed carefully against the risks

Clinical laboratory professionals deserve greater attention in the media for the critical role they play in COVID-19 testing

Recent research describes how individualization with pharmacogenomics may improve the efficiency and safety of these therapies

Study in 38 Michigan hospitals shows need for faster in-hospital testing for coronavirus and other infections, which could reduce overuse of antibiotics

A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient

Implications include clinical diagnostic test under development and targeted therapies

Recent evidence suggests procalcitonin tests may be able to identify COVID-19 patients with bacterial coinfections to guide antibiotic treatment